Mini-tumors predict patients’ response to immunotherapy


Miniature tumors in the lab are able to predict whether the corresponding real-life patients will benefit from immunotherapy. “We’ve solved a major problem many scientists had been facing: preserving a tumors original composition and structure outside of the patient in the lab”, says cancer researcher Daniela Thommen. Today, the results of her study are published in Nature Medicine.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.